Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lithium and drug interactions.

A Amdisen

    Drugs
    |August 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Lithium drug interactions with neuroleptics and diuretics can worsen side effects and lithium toxicity. Careful monitoring and potential lithium withdrawal are advised when using interacting medications.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    No influence from topical application of EMLA cream before blood sampling on routine clinical chemistry and haematology measurements.

    European journal of clinical pharmacology·1991
    Same author

    Change in renal tubular sodium and water handling during progression of polycystic kidney disease: relationship to atrial natriuretic peptide.

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·1990
    Same author

    Abnormal glomerular and tubular function during angiotensin converting enzyme inhibition in renovascular hypertension evaluated by the lithium clearance method.

    European journal of clinical investigation·1989
    Same author

    Atrial natriuretic peptide and exaggerated natriuresis during acute hypertonic volume expansion in essential hypertension.

    Journal of hypertension·1989
    Same author

    Use of lithium in the medically ill.

    Psychotherapy and psychosomatics·1988
    Same author

    Clinical features and management of lithium poisoning.

    Medical toxicology and adverse drug experience·1988
    Same journal

    Ecnoglutide: First Approvals.

    Drugs·2026
    Same journal

    The Long Road to Long-Acting: What Oral PrEP and CAB-LA Teach Us About Scaling Lenacapavir.

    Drugs·2026
    Same journal

    Botulinum Toxin Type A for Trigeminal and Postherpetic Neuralgia: An Umbrella Review of Systematic Reviews.

    Drugs·2026
    Same journal

    Biologics and Small Molecule Inhibitors: Novel Therapeutic Strategies for Cutaneous Adverse Drug Reactions.

    Drugs·2026
    Same journal

    Use of Sedative-Hypnotic Drugs and the Risk of Developing Alzheimer's Disease: A Systematic Review, Meta-Analysis and Meta-Regression.

    Drugs·2026
    Same journal

    Relacorilant: First Approval.

    Drugs·2026
    See all related articles

    Area of Science:

    • Pharmacology
    • Clinical Toxicology
    • Neuroscience

    Background:

    • Lithium is a mood stabilizer with a narrow therapeutic index.
    • Concurrent use of lithium with other medications can lead to complex drug interactions.
    • Understanding these interactions is crucial for patient safety and effective treatment.

    Purpose of the Study:

    • To review and assess the evidence for significant drug interactions involving lithium.
    • To identify medications that pose a high risk when co-administered with lithium.
    • To provide guidance on managing potential lithium drug interactions.

    Main Methods:

    • Literature review of reported lithium drug interactions.
    • Analysis of case reports and clinical studies.

    Related Experiment Videos

  • Assessment of the strength of evidence for specific interactions.

    • Main Results:

    • A high risk of interaction exists between lithium and natriuretic diuretics, potentially causing lithium intoxication.
    • The interaction between lithium and neuroleptic drugs may enhance side effects like tremor and rigidity, but evidence for severe organic brain syndrome is weak.
    • The clinical significance of interactions with neuromuscular blocking agents, phenytoin, carbamazepine, iodide salts, and methyldopa is weakly supported.

    Conclusions:

    • Clinicians should recognize the potential for lithium interactions, particularly with diuretics and neuroleptics.
    • Monitoring lithium serum concentrations is vital to distinguish drug interactions from lithium toxicity.
    • Prophylactic measures, such as temporary lithium withdrawal, may be prudent when initiating potentially interacting drugs.